Nasal Dressings Market (Product Type: Non-biodegradable Nasal Dressings and Biodegradable Nasal Dressings; Material: Chitosan Lactate & Chitosan Hydrochloride, Polyvinyl Alcohol/Polyvinyl Acetate & Polyethylene Glycol, Cellulose & Carboxymethyl Cellulose,

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,795	203 Pages	Transparency Market Research Pvt. Ltd.	May, 2022	TNPR17326537

Best Price Guarantee
Price	from $5,795
Length	203 Pages
Publisher	Transparency Market Research Pvt. Ltd.
Published Date	May, 2022
SKU	TNPR17326537

Nasal Dressings Market (Product Type: Non-biodegradable Nasal Dressings and Biodegradable Nasal Dressings; Material: Chitosan Lactate & Chitosan Hydrochloride, Polyvinyl Alcohol/Polyvinyl Acetate & Polyethylene Glycol, Cellulose & Carboxymethyl Cellulose, Hyaluronic Acid, and Synthetic Polyurethane Foam) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Companies Mentioned

Anika Therapeutics, Inc.
Datt Mediproducts Private Limited
First Aid Bandage Company (FABCO)
Lohmann & Rauscher GmbH & Co. KG
Medtronic plc
Olympus Corporation
Smith & Nephew plc
Stryker Corporation
Summit Medical LLC (Innovia Medical)

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2021

Forecast Year (last) - 2031

Forecast Year ( first) Value - 1.1

Forecast Year (last) Value - 2.7

CAGR % - 0.0901

Currency - US$ Bn

1. Preface: 1.1. Market Definition and Scope; 1.2. Market Segmentation; 1.3. Key Research Objectives; 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Dressings Market
4. Market Overview: 4.1. Introduction; 4.1.1. Product Type Definition; 4.1.2. Industry Evolution / Developments; 4.2. Overview; 4.3. Market Dynamics; 4.3.1. Drivers; 4.3.2. Restraints; 4.3.3. Opportunities; 4.4. Global Nasal Dressings Market Analysis and Forecast, 2017–2031; 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights: 5.1. Technological Advancements; 5.2. Pricing Analysis; 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact); 5.4. Regulatory scenario, by Region/Globally; 5.5. Global Tenders for Nasal Dressing Market
6. Global Nasal Dressings Market Analysis and Forecast, by Product Type: 6.1. Introduction & Definition; 6.2. Key Findings / Developments; 6.3. Market Value Forecast, by Product Type, 2017–2031; 6.3.1. Non-biodegradable (conventional) Nasal Dressings; 6.3.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 6.4. Market Attractiveness Analysis, by Product Type
7. Global Nasal Dressings Market Analysis and Forecast, by Material: 7.1. Introduction & Definition; 7.2. Key Findings / Developments; 7.3. Market Value Forecast, by Material, 2017–2031; 7.3.1. Chitosan Lactate & Chitosan Hydrochloride; 7.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 7.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 7.3.4. Hyaluronic Acid (HA); 7.3.5. Synthetic Polyurethane Foam (SPF); 7.4. Market Attractiveness Analysis, by Material
8. Global Nasal Dressings Market Analysis and Forecast, by Application: 8.1. Introduction & Definition; 8.2. Key Findings / Developments; 8.3. Market Value Forecast, by Application, 2017–2031; 8.3.1. Wound Care; 8.3.2. Epistaxis Management; 8.3.3. Hemostatic Control; 8.3.4. Rhinoplasty; 8.3.5. Septoplasty; 8.3.6. Sinus Surgery; 8.3.7. Others; 8.4. Market Attractiveness Analysis, by Application
9. Global Nasal Dressings Market Analysis and Forecast, by End-user: 9.1. Introduction & Definition; 9.2. Key Findings / Developments; 9.3. Market Value Forecast, by End-user, 2017–2031; 9.3.1. Hospitals & Clinics; 9.3.2. Ambulatory Surgery Centers; 9.3.3. Home Care Settings; 9.4. Market Attractiveness Analysis, by End-user
10. Global Nasal Dressings Market Analysis and Forecast, by Region: 10.1. Key Findings; 10.2. Market Value Forecast, by Region; 10.2.1. North America; 10.2.2. Europe; 10.2.3. Asia Pacific; 10.2.4. Latin America; 10.2.5. Middle East & Africa; 10.3. Market Attractiveness Analysis, by Region
11. North America Nasal Dressings Market Analysis and Forecast: 11.1. Introduction; 11.1.1. Key Findings; 11.2. Market Value Forecast, by Product Type, 2017–2031; 11.2.1. Non-biodegradable (conventional) Nasal Dressings; 11.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 11.3. Market Value Forecast, by Material, 2017–2031; 11.3.1. Chitosan Lactate & Chitosan Hydrochloride; 11.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 11.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 11.3.4. Hyaluronic Acid (HA); 11.3.5. Synthetic Polyurethane Foam (SPF); 11.4. Market Value Forecast, by Application, 2017–2031; 11.4.1. Wound Care; 11.4.2. Epistaxis Management; 11.4.3. Hemostatic Control; 11.4.4. Rhinoplasty; 11.4.5. Septoplasty; 11.4.6. Sinus Surgery; 11.4.7. Others; 11.5. Market Value Forecast, by End-user, 2017–2031; 11.5.1. Hospitals & Clinics; 11.5.2. Ambulatory Surgery Centers; 11.5.3. Home Care Settings; 11.6. Market Value Forecast, by Country, 2017–2031; 11.6.1. U.S.; 11.6.2. Canada; 11.7. Market Attractiveness Analysis; 11.7.1. By Product Type; 11.7.2. By Material; 11.7.3. By Application; 11.7.4. By End-user; 11.7.5. By Country
12. Europe Nasal Dressings Market Analysis and Forecast: 12.1. Introduction; 12.1.1. Key Findings; 12.2. Market Value Forecast, by Product Type, 2017–2031; 12.2.1. Non-biodegradable (conventional) Nasal Dressings; 12.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 12.3. Market Value Forecast, by Material, 2017–2031; 12.3.1. Chitosan Lactate & Chitosan Hydrochloride; 12.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 12.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 12.3.4. Hyaluronic Acid (HA); 12.3.5. Synthetic Polyurethane Foam (SPF); 12.4. Market Value Forecast, by Application, 2017–2031; 12.4.1. Wound Care; 12.4.2. Epistaxis Management; 12.4.3. Hemostatic Control; 12.4.4. Rhinoplasty; 12.4.5. Septoplasty; 12.4.6. Sinus Surgery; 12.4.7. Others; 12.5. Market Value Forecast, by End-user, 2017–2031; 12.5.1. Hospitals & Clinics; 12.5.2. Ambulatory Surgery Centers; 12.5.3. Home Care Settings; 12.6. Market Value Forecast, by Country/Sub-region, 2017–2031; 12.6.1. Germany; 12.6.2. U.K.; 12.6.3. France; 12.6.4. Spain; 12.6.5. Italy; 12.6.6. Rest of Europe; 12.7. Market Attractiveness Analysis; 12.7.1. By Product Type; 12.7.2. By Material; 12.7.3. By Application; 12.7.4. By End-user; 12.7.5. By Country/Sub-region
13. Asia Pacific Nasal Dressings Market Analysis and Forecast: 13.1. Introduction; 13.1.1. Key Findings; 13.2. Market Value Forecast, by Product Type, 2017–2031; 13.2.1. Non-biodegradable (conventional) Nasal Dressings; 13.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 13.3. Market Value Forecast, by Material, 2017–2031; 13.3.1. Chitosan Lactate & Chitosan Hydrochloride; 13.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 13.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 13.3.4. Hyaluronic Acid (HA); 13.3.5. Synthetic Polyurethane Foam (SPF); 13.4. Market Value Forecast, by Application, 2017–2031; 13.4.1. Wound Care; 13.4.2. Epistaxis Management; 13.4.3. Hemostatic Control; 13.4.4. Rhinoplasty; 13.4.5. Septoplasty; 13.4.6. Sinus Surgery; 13.4.7. Others; 13.5. Market Value Forecast, by End-user, 2017–2031; 13.5.1. Hospitals & Clinics; 13.5.2. Ambulatory Surgery Centers; 13.5.3. Home Care Settings; 13.6. Market Value Forecast, by Country/Sub-region, 2017–2031; 13.6.1. China; 13.6.2. Japan; 13.6.3. India; 13.6.4. Australia & New Zealand; 13.6.5. Rest of Asia Pacific; 13.7. Market Attractiveness Analysis; 13.7.1. By Product Type; 13.7.2. By Material; 13.7.3. By Application; 13.7.4. By End-user; 13.7.5. By Country/Sub-region
14. Latin America Nasal Dressings Market Analysis and Forecast: 14.1. Introduction; 14.1.1. Key Findings; 14.2. Market Value Forecast, by Product Type, 2017–2031; 14.2.1. Non-biodegradable (conventional) Nasal Dressings; 14.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 14.3. Market Value Forecast, by Material, 2017–2031; 14.3.1. Chitosan Lactate & Chitosan Hydrochloride; 14.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 14.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 14.3.4. Hyaluronic Acid (HA); 14.3.5. Synthetic Polyurethane Foam (SPF); 14.4. Market Value Forecast, by Application, 2017–2031; 14.4.1. Wound Care; 14.4.2. Epistaxis Management; 14.4.3. Hemostatic Control; 14.4.4. Rhinoplasty; 14.4.5. Septoplasty; 14.4.6. Sinus Surgery; 14.4.7. Others; 14.5. Market Value Forecast, by End-user, 2017–2031; 14.5.1. Hospitals & Clinics; 14.5.2. Ambulatory Surgery Centers; 14.5.3. Home Care Settings; 14.6. Market Value Forecast, by Country/Sub-region, 2017–2031; 14.6.1. Brazil; 14.6.2. Mexico; 14.6.3. Rest of Latin America; 14.7. Market Attractiveness Analysis; 14.7.1. By Product Type; 14.7.2. By Material; 14.7.3. By Application; 14.7.4. By End-user; 14.7.5. By Country/Sub-region
15. Middle East & Africa Nasal Dressings Market Analysis and Forecast: 15.1. Introduction; 15.1.1. Key Findings; 15.2. Market Value Forecast, by Product Type, 2017–2031; 15.2.1. Non-biodegradable (conventional) Nasal Dressings; 15.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings; 15.3. Market Value Forecast, by Material, 2017–2031; 15.3.1. Chitosan Lactate & Chitosan Hydrochloride; 15.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG); 15.3.3. Cellulose & Carboxymethyl Cellulose (CMC); 15.3.4. Hyaluronic Acid (HA); 15.3.5. Synthetic Polyurethane Foam (SPF); 15.4. Market Value Forecast, by Application, 2017–2031; 15.4.1. Wound Care; 15.4.2. Epistaxis Management; 15.4.3. Hemostatic Control; 15.4.4. Rhinoplasty; 15.4.5. Septoplasty; 15.4.6. Sinus Surgery; 15.4.7. Others; 15.5. Market Value Forecast, by End-user, 2017–2031; 15.5.1. Hospitals & Clinics; 15.5.2. Ambulatory Surgery Centers; 15.5.3. Home Care Settings; 15.6. Market Value Forecast, by Country/Sub-region, 2017–2031; 15.6.1. GCC Countries; 15.6.2. South Africa; 15.6.3. Rest of Middle East & Africa; 15.7. Market Attractiveness Analysis; 15.7.1. By Product Type; 15.7.2. By Material; 15.7.3. By Application; 15.7.4. By End-user; 15.7.5. By Country/Sub-region
16. Competition Landscape: 16.1. Market Player - Competition Matrix (by tier and size of companies); 16.2. Market Share Analysis, by Region/Global; 16.3. Company Profiles; 16.3.1. Anika Therapeutics, Inc.; 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.1.2. Product Portfolio; 16.3.1.3. Financial Overview; 16.3.1.4. SWOT Analysis; 16.3.1.5. Strategic Overview; 16.3.2. Datt Mediproducts Private Limited; 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.2.2. Product Portfolio; 16.3.2.3. SWOT Analysis; 16.3.2.4. Strategic Overview; 16.3.3. First Aid Bandage Company (FABCO); 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.3.2. Product Portfolio; 16.3.3.3. SWOT Analysis; 16.3.4. Lohmann & Rauscher GmbH & Co. KG; 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.4.2. Product Portfolio; 16.3.4.3. SWOT Analysis; 16.3.5. Medtronic plc; 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.5.2. Product Portfolio; 16.3.5.3. Financial Overview; 16.3.5.4. SWOT Analysis; 16.3.5.5. Strategic Overview; 16.3.6. Olympus Corporation; 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.6.2. Product Portfolio; 16.3.6.3. Financial Overview; 16.3.6.4. SWOT Analysis; 16.3.6.5. Strategic Overview; 16.3.7. Smith & Nephew plc; 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.7.2. Product Portfolio; 16.3.7.3. Financial Overview; 16.3.7.4. SWOT Analysis; 16.3.7.5. Strategic Overview; 16.3.8. Stryker Corporation; 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.8.2. Product Portfolio; 16.3.8.3. Financial Overview; 16.3.8.4. SWOT Analysis; 16.3.8.5. Strategic Overview; 16.3.9. Summit Medical LLC (Innovia Medical); 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength); 16.3.9.2. Product Portfolio; 16.3.9.3. SWOT Analysis